a2 Milk Company
A2M.ASXConsumer Staples
Sale of branded products in targeted markets made with milk naturally containing the A2 beta-casein protein type.
Market Data
$7.020
-0.0%$5.1B
27.6x
$0.310
2.40%
-0.1%
Recent Announcements
Becoming a substantial holder
UBS Group AG became a substantial holder (5.328%).
Becoming a substantial holder
FirstCape Group Limited became a substantial holder (5.086%).
Becoming a substantial holder
J.P. Morgan Chase & Co. and its affiliates became a substantial holder (5.14%).
Becoming a substantial holder
Paradice Investment Management Pty Ltd (ABN 64 090 148 619) became a substantial holder (5.4185%).
Ceasing to be a substantial holder
JP Morgan Chase & Co. and its affiliates ceased to be a substantial holder (5.10%).
Becoming a substantial holder
J.P. Morgan Chase & Co. and its affiliates became a substantial holder (5.10%).
Ceasing to be a substantial holder from CGF
CGF ceased to be a substantial holder.
Ceasing to be a substantial holder
Challenger Limited (ACN 106 842 371) and the entities listed in Annexure 2 ceased to be a substantial holder (5.07%).
Ceasing to be a substantial holder
Alphinity Investment Management Pty Ltd ceased to be a substantial holder.
Trading, Supply Chain and Outlook Update
The a2 Milk Company (NZX: ATM, ASX: A2M) reported strong demand for its infant milk formula products in Q3 2026 but is experiencing temporary supply chain disruptions in China due to freight delays from Middle East conflict, production backlogs at supplier Synlait, and enhanced customs clearance requirements, leading to downgraded FY26 guidance with lower revenue growth (low to mid double-digit vs. previously mid double-digit), reduced EBITDA margins (14.0-14.5% vs. 15.5-16.0%), and NPAT expected to be similar to or down versus FY25.
Get real-time alerts for A2M
Receive AI-powered earnings summaries and instant notifications when a2 Milk Company releases results.
Register Free